InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Lynch Daniel, Director. Director active across 4 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 14 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €6.2m. Activity tracked since 20 May 2021. The latest transaction was filed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lynch Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
93,004 sharesCommon StockSEC:0001104659-25-065321:0
10,060 shares0Common StockSEC:0001104659-25-049662:0
44,018 shares@ US$60.138741.2% of flowCommon StockSEC:0001104659-25-016614:0
400 shares@ US$60.000.4% of flowCommon StockSEC:0001104659-25-015215:0
69,766 shares@ US$53.228758.4% of flowCommon StockSEC:0001104659-25-012364:0
4,095 shares0Common StockSEC:0001104659-24-062992:0
8,400 shares0Common StockSEC:0001562180-23-005219:0
4,648 shares0Common StockSEC:0001104659-23-064648:0
7,200 shares0Common StockSEC:0001562180-22-004992:0
4,818 shares0Common StockSEC:0001104659-22-063508:0
00Common StockSEC:0001628280-21-023649:0
2,803 shares0Common StockSEC:0001628280-21-023471:0
4,353 shares0Common StockSEC:0001562180-21-004349:0
1,106 shares0Common StockSEC:0001104659-21-070515:0
14 of 14 declarations
About Lynch Daniel
Administrateur of SpringWorks Therapeutics, Inc., 2seventy bio, Inc. and bluebird bio, Inc., LYNCH DANIEL has 14 filings in total. Across the 14 sampled filings, the period covered runs from 2021-05-21 to 2025-07-02, with 0 in buys and 6164510 in sales, mainly in SpringWorks Therapeutics, Inc.
